Guru Ownership Trend
Guru Analysis for Recursion Pharmaceuticals, Inc. (RXRX)
Recursion Pharmaceuticals, Inc. (RXRX), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $134.42 M.
Top institutional holders include Catherine Wood and Steven Cohen.
Institutional sentiment is currently Bullish. This is evidenced by a $18.03 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Recursion Pharmaceuticals, Inc. (RXRX)
Major holders include Catherine Wood ($152.63 M), Steven Cohen ($2.68 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 37.97 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $18.03 M, with 2 managers increasing positions and 1 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited RXRX. The total reported sell value was $72,761.
Yes, 1 managers opened new positions in RXRX, and 1 increased their existing holdings. The total reported buy value was $18.1 M.